Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Erik Manting currently holds 70,000 shares of Transcode Therapeutics, Inc. (RNAZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erik Manting has been a net neutral trader of RNAZ stock. They have purchased $0 and sold $0 worth of shares.
Erik Manting's most recent insider trade was on Jun 14, 2024, when they sold 70,000 shares at $0.00 per share.
Erik Manting serves as Executive at Transcode Therapeutics, Inc. (RNAZ). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Erik Manting holds the position of Executive at Transcode Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Erik Manting has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Erik Manting was on Jun 14, 2024, when they purchased $0 worth of RNAZ shares. This transaction involved 70,000 shares at N/A per share.
Erik Manting currently owns 70,000 shares of Transcode Therapeutics, Inc. (RNAZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Erik Manting's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Erik Manting has 1 Form 4 filings on record as an insider at Transcode Therapeutics, Inc..
Set alerts for Erik Manting and 40,000+ other insiders.